Intervention not reported
Seizure freedom (3‐month blinded evaluation period) · adults with IQ > 70 with refractory focal epilepsy
The intervention showed no clear difference in seizure freedom (3‐month blinded evaluation period) (moderate certainty).
1 finding from 1 review
Intervention not reported
Seizure freedom (1‐ to 3‐month blinded evaluation period) · patients with refractory (multi)focal or generalized epilepsy
The intervention showed no clear difference in seizure freedom (1‐ to 3‐month blinded evaluation period) (moderate certainty).
1 finding from 1 review
Intervention not reported
Seizure freedom (3‐month blinded evaluation period) · adults with IQ >70 with refractory focal epilepsy
The intervention showed no clear difference in seizure freedom (3‐month blinded evaluation period) (low certainty).
1 finding from 1 review
OR 1 [0.07, 13.64]
1 study · 4 participants
Low
Intervention not reported
Seizure freedom (3‐month blinded evaluation period) · adults with refractory focal epilepsy (1 or 2 epileptogenic regions)
The intervention showed no clear difference in seizure freedom (3‐month blinded evaluation period) (moderate certainty).
1 finding from 1 review
Intervention not reported
Seizure freedom (3‐month blinded evaluation period) · patients with refractory (multi)focal or generalized epilepsy
It is very uncertain whether the intervention changes seizure freedom (3‐month blinded evaluation period) (very low certainty).
1 finding from 1 review
OR 1 [0.11, 9.39]
1 study · 6 participants
Very low
Intervention not reported
Seizure freedom (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
The intervention showed no clear difference in seizure freedom (1‐ to 3‐month blinded evaluation periods) (moderate certainty).
1 finding from 1 review